Professor | Dehong Yan | Asia Growth Partners

Name

Dehong Yan

Contact Information

dh.yan@siat.ac.cn

Language ability

Chinese, English

Province

Guangdong

University/Lab Affiliation and Title	University of Chinese Academy of Sciences
Faculty	Medical School
Academic Background & Achievements	2010-09 to 2013-06 PhD: Sun Yat-sen University 2007-09 to 2010-07 Master's: South China Agricultural University 2003-09 to 2007-07 Bachelor's: Hubei University
Work Experience	2023-06 to Present - Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences - Associate Researcher/Doctoral Supervisor 2020-01 to Present - Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences - Associate Researcher/Master's Supervisor 2017-01 to 2019-12 - Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences - Assistant Researcher 2014-09 to 2016-12 - Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences - Postdoctoral Researcher 2013-07 to 2014-08 - Guangzhou Yongnuo Biotechnology Co., Ltd. - Deputy Technical Director
Awards	AAI Early Career Faculty Grant (2021): National Level AAI Travel Grants for IUIS (2019): National Level AAI Travel Grants for the 5th European Congress of Immunology (2018): National Level

University/Lab Affiliation and Title

University of Chinese Academy of Sciences

Faculty

Medical School

Academic Background & Achievements

Work Experience

2023-06 to Present - Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences - Associate Researcher/Doctoral Supervisor
2020-01 to Present - Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences - Associate Researcher/Master's Supervisor
2017-01 to 2019-12 - Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences - Assistant Researcher
2014-09 to 2016-12 - Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences - Postdoctoral Researcher
2013-07 to 2014-08 - Guangzhou Yongnuo Biotechnology Co., Ltd. - Deputy Technical Director

Awards

AAI Early Career Faculty Grant (2021): National Level
AAI Travel Grants for IUIS (2019): National Level
AAI Travel Grants for the 5th European Congress of Immunology (2018): National Level

Areas of Focus	Myeloid-Derived Suppressor Cells (MDSC) and Macrophages in Cancer
Publications	Regulating Histone Deacetylase Signaling Pathways of Myeloid-Derived Suppressor Cells Enhanced T Cell-Based Immunotherapy, Dehong Yan, 2022 Targeting inhibition of accumulation and function of myeloid-derived suppressor cells by artemisinin via PI3K/AKT, mTOR and MAPK pathways enhances anti-PD-L1 immunotherapy in melanoma and liver tumors, Dehong Yan, 2022 Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy, Dehong Yan, 2021 Lipidomics data on the effect of lipofermata on myeloid-derived suppressor cells in the spleens of tumor-bearing mice., Dehong Yan, 2021 High Expression of BCL11A Predicts Poor Prognosis for Childhood MLL-r ALL, Dehong Yan, 2021 TIPE2 specifies the functional polarization of myeloid-derived suppressor cells during tumorigenesis, Dehong Yan, 2020 Blockade of myeloid-derived suppressor cell function by valproic acid enhanced anti-PD-L1 tumor immunotherapy, Dehong Yan, 2020 Lipid Metabolic Pathways Confer the Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor, Dehong Yan, 2019 青蒿素类药物靶标及其免疫调节抗肿瘤机制研究进展, 鄢德洪, 2018 Polyunsaturated fatty acids promote the expansion of myeloid-derived suppressor cells by activating JAK2/STAT3 pathway., Dehong Yan, 2013

Areas of Focus

Myeloid-Derived Suppressor Cells (MDSC) and Macrophages in Cancer

Publications

Regulating Histone Deacetylase Signaling Pathways of Myeloid-Derived Suppressor Cells Enhanced T Cell-Based Immunotherapy, Dehong Yan, 2022
Targeting inhibition of accumulation and function of myeloid-derived suppressor cells by artemisinin via PI3K/AKT, mTOR and MAPK pathways enhances anti-PD-L1 immunotherapy in melanoma and liver tumors, Dehong Yan, 2022
Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy, Dehong Yan, 2021
Lipidomics data on the effect of lipofermata on myeloid-derived suppressor cells in the spleens of tumor-bearing mice., Dehong Yan, 2021
High Expression of BCL11A Predicts Poor Prognosis for Childhood MLL-r ALL, Dehong Yan, 2021
TIPE2 specifies the functional polarization of myeloid-derived suppressor cells during tumorigenesis, Dehong Yan, 2020
Blockade of myeloid-derived suppressor cell function by valproic acid enhanced anti-PD-L1 tumor immunotherapy, Dehong Yan, 2020
Lipid Metabolic Pathways Confer the Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor, Dehong Yan, 2019
青蒿素类药物靶标及其免疫调节抗肿瘤机制研究进展, 鄢德洪, 2018
Polyunsaturated fatty acids promote the expansion of myeloid-derived suppressor cells by activating JAK2/STAT3 pathway., Dehong Yan, 2013

Cancer Mdsc Macrophage Immunotherapy Tumor Cellular Immunology Signal Pathways Histone Deacetylase Pi3K/Akt Mtor

Jun Tian - Southern University of Science and Technology

Peng Tan - Southern University of Science and Technology

Siyuan Xia - Southern University of Science and Technology

View All

Personal Information